Signe Sørensen Torekov

Signe Sørensen Torekov

Professor


  1. Udgivet

    Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial

    Jensen, Simon Birk Kjær, Sørensen, V., Sandsdal, Rasmus Michael, Lehmann, E. W., Lundgren, J. R., Juhl, C. R., Janus, C., Ternhamar, T., Stallknecht, Bente Merete, Holst, Jens Juul, Jørgensen, Niklas Rye, Jensen, Jens-Erik Beck, Madsbad, Sten & Torekov, Signe Sørensen, 2024, I: JAMA network open. 7, 6, 13 s., e2416775.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  2. Udgivet
  3. Udgivet

    Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity

    Matias, I., Lehmann, E. W., Zizzari, P., Byberg, Sarah, Cota, D., Torekov, Signe Sørensen & Quarta, C., 2024, I: Journal of Endocrinological Investigation. 43, s. 1289–1294

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  4. Udgivet
  5. Udgivet

    Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial

    Quist, Jonas Salling, Pedersen, H. E., Jensen, M. M., Clemmensen, K. K. B., Bjerre, N., Ekblond, T. S., Uldal, S., Størling, Joachim, Albrechtsen, Nicolai Jacob Wewer, Holst, Jens Juul, Torekov, Signe Sørensen, Nyeland, M. E., Vistisen, D., Jørgensen, M. E., Panda, S., Brock, C., Finlayson, G., Blond, Martin Bæk & Færch, K., 2024, I: The Lancet Healthy Longevity. 5, 5, s. e314-e325 12 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

ID: 5761